Assenagon Asset Management
ALDX icon

Assenagon Asset Management’s Aldeyra Therapeutics ALDX Stock Holding History

Assenagon Asset Management’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-645,020
Closed -$6.41M – 1323
2023
Q1 		$6.41M Hold
645,020
– – 0.02% 501
2022
Q4 		$4.49M Sell
645,020
-450
-0.1% -$2.57K 0.02% 559
2022
Q3 		$3.45M Sell
645,470
-1,347
-0.2% -$8.08K 0.01% 567
2022
Q2 		$2.58M Sell
646,817
-328,322
-34% -$1.13M 0.01% 737
2022
Q1 		$4.33M Buy
975,139
+948,747
+3,595% +$3.78M 0.01% 561
2021
Q4 		$106K Sell
26,392
-42,827
-62% -$327K ﹤0.01% 1394
2021
Q3 		$608K Sell
69,219
-569,094
-89% -$5.22M ﹤0.01% 1024
2021
Q2 		$7.23M Buy
638,313
+584,539
+1,087% +$7.03M 0.02% 405
2021
Q1 		$639K Sell
53,774
-215,409
-80% -$2.48M ﹤0.01% 998
2020
Q4 		$1.85M Sell
269,183
-205,093
-43% -$1.44M 0.01% 543
2020
Q3 		$3.51M Buy
+474,276
New +$3.06M 0.02% 434

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Assenagon Asset Management's ALDX Position: Q2 2023 in Review

Assenagon Asset Management sold out of Aldeyra Therapeutics (ALDX) in Q2 2023, closing a stake of 645,020 shares — an estimated $6.41M sold.

Assenagon Asset Management first reported a position in ALDX in Q3 2020 and held it in 11 quarters. The position peaked at $7.23M in Q2 2021. 119 funds tracked by Wall St. Rank hold ALDX as of Q2 2023.

  • Assenagon Asset Management reported no remaining Aldeyra Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Assenagon Asset Management sold 645,020 Aldeyra Therapeutics shares in Q2 2023, an estimated $6.41M.
  • Assenagon Asset Management first reported a position in Aldeyra Therapeutics in Q3 2020 and held it in 11 quarters.
  • Assenagon Asset Management's Aldeyra Therapeutics position peaked at $7.23M in Q2 2021.
  • 119 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2023.

Based on Assenagon Asset Management's 13F filing for Q2 2023, filed 25 Jul 2023.